Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/24122
Title: | Durable reduction in MRI disease activity with alemtuzumab in treatment-naive patients with active relapsing-remitting multiple sclerosis: 6-year follow-up of the CARE-MS I study | Authors: | Arnold, D. L. Barnett, M. Comi, G. Giovannoni, G. Pelletier, D. Rovira, A. Schippling, S. VAN WIJMEERSCH, Bart Margolin, D. H. Thangavelu, K. Traboulsee, A. |
Issue Date: | 2016 | Publisher: | SAGE PUBLICATIONS LTD | Source: | MULTIPLE SCLEROSIS JOURNAL, 22(S3), p. 329-329 (Art N° P683) | Notes: | [Arnold, D. L.] NeuroRx Res, Montreal, PQ, Canada. [Arnold, D. L.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada. [Barnett, M.] Univ Sydney, Sydney, NSW, Australia. [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. [Giovannoni, G.] Queen Mary Univ London, Barts & London Sch Med, London, England. [Pelletier, D.] Univ Southern Calif, Los Angeles, CA USA. [Rovira, A.] Vall dHebron Univ Hosp, Barcelona, Spain. [Schippling, S.] Univ Zurich Hosp, Neuroimmunol & Multiple Sclerosis Res, Zurich, Switzerland. [Schippling, S.] Univ Zurich, Zurich, Switzerland. [Van Wijmeersch, B.] Univ Hasselt, Hasselt, Belgium. [Margolin, D. H.; Thangavelu, K.] Sanofi Genzyme, Cambridge, MA USA. [Traboulsee, A.] Univ British Columbia, Vancouver, BC, Canada. | Document URI: | http://hdl.handle.net/1942/24122 | ISSN: | 1352-4585 | e-ISSN: | 1477-0970 | ISI #: | 000383267201422 | Category: | M | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
10.1177@1352458516663081.pdf Restricted Access | Published version | 389.97 kB | Adobe PDF | View/Open Request a copy |
WEB OF SCIENCETM
Citations
2
checked on Oct 14, 2024
Page view(s)
16
checked on Sep 6, 2022
Download(s)
8
checked on Sep 6, 2022
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.